LaPorte; Matthew G.
Patent Applications and Registrations
Patent applications and USPTO patent grants for LaPorte; Matthew G..The latest application filed is for "targeted nitroxide compounds and their use in treating ferroptosis-related diseases".
Company Profile
12.35.44
- LaPorte; Matthew G. - Seven Fields PA
- Laporte; Matthew G. - Honeybrook PA
- LaPorte; Matthew G. - Pittsburgh PA
- Laporte; Matthew G. - Honey Brook PA
- LAPORTE; Matthew G. - Malvern PA
Patent Activity
| Patent | Date |
|---|---|
| Targeted Nitroxide Compounds and Their Use in Treating Ferroptosis-Related Diseases App 20220259149 - Wipf; Peter ; et al. | 2022-08-18 |
| SMAC mimetic Grant 11,351,221 - Condon , et al. June 7, 2 | 2022-06-07 |
| Methods Of Treatment Using Phenyl Indole Allosteric Inhibitors Of P97 Atpase App 20220112179 - Huryn; Donna M. ; et al. | 2022-04-14 |
| Modulators Of P97 Aaa Atpase Activity App 20220089565 - Huryn; Donna M. ; et al. | 2022-03-24 |
| Phenyl indole allosteric inhibitors of P97 ATPase Grant 11,247,985 - Huryn , et al. February 15, 2 | 2022-02-15 |
| Modulators of P97 AAA ATPase activity Grant 11,214,560 - Huryn , et al. January 4, 2 | 2022-01-04 |
| 6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]t- hiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity Grant 11,111,253 - Huryn , et al. September 7, 2 | 2021-09-07 |
| Modulators Of P97 Aaa Atpase Activity App 20210070732 - HURYN; Donna M. ; et al. | 2021-03-11 |
| Modulators of P97 AAA ATPase activity Grant 10,894,782 - Huryn , et al. January 19, 2 | 2021-01-19 |
| 6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]t- hiadiazines as Inhibitors of the STAT3 Pathway with Anti-Proliferative Activity App 20200339602 - Huryn; Donna M. ; et al. | 2020-10-29 |
| SMAC Mimetic App 20200282002 - Condon; Stephen M. ; et al. | 2020-09-10 |
| Modulators Of P97 Aaa Atpase Activity App 20200216410 - Huryn; Donna M. ; et al. | 2020-07-09 |
| Phenyl Indole Allosteric Inhibitors Of P97 Atpase App 20200157082 - Huryn; Donna M. ; et al. | 2020-05-21 |
| Phenyl indole allosteric inhibitors of p97 ATPase Grant 10,633,370 - Huryn , et al. | 2020-04-28 |
| 6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-B][1,3,4]t- hiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity Grant 10,618,914 - Huryn , et al. | 2020-04-14 |
| SMAC mimetic Grant 10,596,220 - Condon , et al. | 2020-03-24 |
| SMAC Mimetic App 20190255139 - Condon; Stephen M. ; et al. | 2019-08-22 |
| Modulators Of P97 Aaa Atpase Activity App 20190185448 - HURYN; Donna M. ; et al. | 2019-06-20 |
| SMAC mimetic Grant 10,314,881 - Condon , et al. | 2019-06-11 |
| 6-aryl-7-substituted-3-(1h-pyrazol-5-yl)-7h-[1,2,4]triazolo[3,4-b][1,3,4]t- Hiadiazines As Inhibitors Of The Stat3 Pathway With Anti-proliferative Activity App 20190100535 - Huryn; Donna M. ; et al. | 2019-04-04 |
| Phenyl Indole Allosteric Inhibitors Of P97 Atpase App 20180319778 - HURYN; Donna M. ; et al. | 2018-11-08 |
| SMAC Mimetic App 20180303897 - Condon; Stephen M. ; et al. | 2018-10-25 |
| SMAC Mimetic Grant 10,034,912 - Condon , et al. July 31, 2 | 2018-07-31 |
| Dimeric IAP inhibitors Grant 9,920,093 - Condon , et al. March 20, 2 | 2018-03-20 |
| IAP binding compounds Grant 9,840,464 - Condon , et al. December 12, 2 | 2017-12-12 |
| SMAC Mimetic App 20170182116 - Condon; Stephen M. ; et al. | 2017-06-29 |
| Dimeric IAP Inhibitors App 20160355547 - Condon; Stephen M. ; et al. | 2016-12-08 |
| IAP Binding Compounds App 20160289183 - Condon; Stephen M. ; et al. | 2016-10-06 |
| IAP binding compounds Grant 9,394,249 - Condon , et al. July 19, 2 | 2016-07-19 |
| Dimeric IAP Inhibitors App 20160052965 - Condon; Stephen M. ; et al. | 2016-02-25 |
| Dimeric IAP inhibitors Grant 9,187,490 - Condon , et al. November 17, 2 | 2015-11-17 |
| IAP Binding Compounds App 20150307448 - Condon; Stephen M. ; et al. | 2015-10-29 |
| SMAC Mimetic for Treating Myelodysplastic Syndromes App 20150158908 - Condon; Stephen M. ; et al. | 2015-06-11 |
| SMAC mimetic for treating myelodysplastic syndromes Grant 8,986,993 - Condon , et al. March 24, 2 | 2015-03-24 |
| Dimeric IAP Inhibitors App 20140329823 - Condon; Stephen M. ; et al. | 2014-11-06 |
| Dimeric IAP inhibitors Grant 8,822,525 - Condon , et al. September 2, 2 | 2014-09-02 |
| IAP binding compounds Grant 8,802,716 - Condon , et al. August 12, 2 | 2014-08-12 |
| SMAC Mimetic App 20140073579 - Condon; Stephen M. ; et al. | 2014-03-13 |
| SMAC mimetic Grant 8,603,816 - Condon , et al. December 10, 2 | 2013-12-10 |
| Dimeric Iap Inhibitors App 20130289042 - CONDON; Stephen M. ; et al. | 2013-10-31 |
| Iap Binding Compounds App 20130289075 - Condon; Stephen M. ; et al. | 2013-10-31 |
| Iap Inhibitors App 20130274278 - CONDON; Stephen M. ; et al. | 2013-10-17 |
| Dimeric IAP inhibitors Grant 8,497,297 - Condon , et al. July 30, 2 | 2013-07-30 |
| IAP inhibitors Grant 8,481,495 - Condon , et al. July 9, 2 | 2013-07-09 |
| IAP inhibitors Grant 8,415,486 - Condon , et al. April 9, 2 | 2013-04-09 |
| IAP inhibitors Grant 8,399,683 - Condon , et al. March 19, 2 | 2013-03-19 |
| SMAC Mimetic App 20130012564 - CONDON; Stephen M. ; et al. | 2013-01-10 |
| 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic Grant 8,283,372 - Condon , et al. October 9, 2 | 2012-10-09 |
| IAP Inhibitors App 20120157390 - CONDON; Stephen M. ; et al. | 2012-06-21 |
| Iap Inhibitors App 20120135990 - Condon; Stephen M. ; et al. | 2012-05-31 |
| Smac Mimetec App 20120115922 - Condon; Stephen M. ; et al. | 2012-05-10 |
| Iap Inhibitors App 20120094917 - Condon; Stephen M. ; et al. | 2012-04-19 |
| IAP inhibitors Grant 8,143,426 - Condon , et al. March 27, 2 | 2012-03-27 |
| Dimeric Iap Antagonists App 20110305777 - Condon; Stephen M. ; et al. | 2011-12-15 |
| Dimeric Iap Inhibitors App 20110301151 - Condon; Stephen M. ; et al. | 2011-12-08 |
| Iap Binding Compounds App 20110294827 - Condon; Stephen M. ; et al. | 2011-12-01 |
| Iap Inhibitors App 20110288116 - Condon; Stephen M. ; et al. | 2011-11-24 |
| Iap Inhibitors App 20110237517 - Condon; Stephen M. ; et al. | 2011-09-29 |
| Dimeric IAP inhibitors Grant 8,022,230 - Condon , et al. September 20, 2 | 2011-09-20 |
| Dimeric IAP inhibitors Grant 7,985,735 - Condon , et al. July 26, 2 | 2011-07-26 |
| IAP binding compounds Grant 7,968,590 - Condon , et al. June 28, 2 | 2011-06-28 |
| SMAC Mimetic App 20110003877 - Condon; Stephen M. ; et al. | 2011-01-06 |
| Dimeric Iap Inhibitors App 20100075911 - CONDON; Stephen M. ; et al. | 2010-03-25 |
| Dimeric IAP inhibitors Grant 7,517,906 - Condon , et al. April 14, 2 | 2009-04-14 |
| Iap Binding Compounds App 20090048183 - Condon; Stephen M. ; et al. | 2009-02-19 |
| IAP binding compounds Grant 7,456,209 - Condon , et al. November 25, 2 | 2008-11-25 |
| Dimeric Iap Inhibitors App 20080020986 - Condon; Stephen M. ; et al. | 2008-01-24 |
| Iap Inhibitors App 20080021066 - Condon; Stephen M. ; et al. | 2008-01-24 |
| Pyranouidole Derivatives and the Use Thereof for the Treatment of Hepatitis C Virus Infection or Disease App 20070219212 - Condon; Stephen M. ; et al. | 2007-09-20 |
| Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus Grant 7,217,730 - Gopalsamy , et al. May 15, 2 | 2007-05-15 |
| Dimeric IAP inhibitors App 20060194741 - Condon; Stephen M. ; et al. | 2006-08-31 |
| IAP binding compounds App 20060025347 - Condon; Stephen M. ; et al. | 2006-02-02 |
| Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus App 20040082643 - Gopalsamy, Ariamala ; et al. | 2004-04-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 